Literature DB >> 8698872

No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia.

C Stein1, M Pflüger, A Yassouridis, J Hoelzl, K Lehrberger, C Welte, A H Hassan.   

Abstract

Pain treatment with centrally acting opiates is limited by tolerance. Tolerance is a decreasing effect of a drug with prolonged administration of that drug or of a related (e.g., endogenous) compound acting at the same receptor. This is often associated with a downregulation of receptors. In peripheral inflamed tissue, both locally expressed opioid peptides and morphine can produce powerful analgesia mediated by similar populations of opioid receptors. We hypothesized that the chronic presence of endogenous opioids in inflamed joints might convey downregulation of peripheral opioid receptors and tolerance to the analgesic effects of intraarticular morphine. We assessed these effects after arthroscopic surgery in patients with and without histologically verified synovial cellular infiltration, and we examined synovial opioid peptides and opioid receptors by immunocytochemistry and autoradiography, respectively. We found that, despite an abundance of opioid-containing cells in pronounced synovitis, morphine is at least as effective as in patients without such cellular infiltrations, and there is no major downregulation of peripheral opioid receptors. Thus, opioids expressed in inflamed tissue do not produce tolerance to peripheral morphine analgesia. Tolerance may be less pronounced for peripherally than for centrally acting opioids, which provides a promising perspective for the treatment of chronic pain in arthritis and other inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698872      PMCID: PMC507490          DOI: 10.1172/JCI118852

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

Review 1.  Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation.

Authors:  A Barber; R Gottschlich
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

2.  Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception.

Authors:  R Przewłocki; A H Hassan; W Lason; C Epplen; A Herz; C Stein
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

3.  Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.

Authors:  C Stein; A H Hassan; R Przewłocki; C Gramsch; K Peter; A Herz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 4.  Control of receptor sensitivity at the mRNA level.

Authors:  B J Morris
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

Review 5.  Peripheral mechanisms of opioid analgesia.

Authors:  C Stein
Journal:  Anesth Analg       Date:  1993-01       Impact factor: 5.108

6.  Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.

Authors:  D E Selley; C S Breivogel; S R Childers
Journal:  Mol Pharmacol       Date:  1993-10       Impact factor: 4.436

7.  Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue.

Authors:  A H Hassan; A Ableitner; C Stein; A Herz
Journal:  Neuroscience       Date:  1993-07       Impact factor: 3.590

8.  Local analgesic effect of endogenous opioid peptides.

Authors:  C Stein; A H Hassan; K Lehrberger; J Giefing; A Yassouridis
Journal:  Lancet       Date:  1993-08-07       Impact factor: 79.321

9.  Analgesic effect of intraarticular morphine after arthroscopic knee surgery.

Authors:  C Stein; K Comisel; E Haimerl; A Yassouridis; K Lehrberger; A Herz; K Peter
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

10.  Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.

Authors:  M Schäfer; L Carter; C Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more
  29 in total

Review 1.  [Do opioids induce hyperalgesia?].

Authors:  C Zöllner
Journal:  Anaesthesist       Date:  2010-11       Impact factor: 1.041

2.  Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats.

Authors:  P J Cabot; L Carter; C Gaiddon; Q Zhang; M Schäfer; J P Loeffler; C Stein
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 3.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

Review 4.  Recent Advances in Peripheral Opioid Receptor Therapeutics.

Authors:  Raghav Seth; Sumanth S Kuppalli; Danielle Nadav; Grant Chen; Amitabh Gulati
Journal:  Curr Pain Headache Rep       Date:  2021-05-10

Review 5.  Indications for Opioid Antagonists.

Authors:  O J Michael Coppes; Christine N Sang
Journal:  Curr Pain Headache Rep       Date:  2017-06

6.  Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.

Authors:  I Bileviciute-Ljungar; M Spetea
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

7.  Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.

Authors:  M Hiramatsu; K Inoue; A Ambo; Y Sasaki; T Kameyama
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 8.  [Pain inhibition by opioids-new concepts].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

9.  Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.

Authors:  Hitoshi Yokoyama; Tomohiko Oguchi; William F Goins; James R Goss; Osamu Nishizawa; William C de Groat; Darren Wolfe; David M Krisky; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2013-02-14       Impact factor: 5.695

10.  Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain.

Authors:  Halina Machelska; Matthias Schroff; Detlef Oswald; Waltraud Binder; Nicolle Sitte; Shaaban A Mousa; Heike L Rittner; Alexander Brack; Dominika Labuz; Melanie Busch; Burghardt Wittig; Michael Schäfer; Christoph Stein
Journal:  Mol Pain       Date:  2009-12-14       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.